291 related articles for article (PubMed ID: 9876340)
1. Increased incidence of neoplasia in patients with pituitary adenomas. The Pituitary Study Group.
Popovic V; Damjanovic S; Micic D; Nesovic M; Djurovic M; Petakov M; Obradovic S; Zoric S; Simic M; Penezic Z; Marinkovic J
Clin Endocrinol (Oxf); 1998 Oct; 49(4):441-5. PubMed ID: 9876340
[TBL] [Abstract][Full Text] [Related]
2. The incidence rate of pituitary adenomas in western Sweden for the period 2001-2011.
Tjörnstrand A; Gunnarsson K; Evert M; Holmberg E; Ragnarsson O; Rosén T; Filipsson Nyström H
Eur J Endocrinol; 2014 Oct; 171(4):519-26. PubMed ID: 25084775
[TBL] [Abstract][Full Text] [Related]
3. Glycoprotein hormone alpha-subunit secretion in prolactinomas and in non-functioning adenomas: relation with the tumour size.
Warnet A; Porsova-Dutoit I; Lahlou N; Seret-Begue D; Lajeunie E; Chanson P; Woimant F; Lot G; Guillausseau PJ; Roger M
Clin Endocrinol (Oxf); 1994 Aug; 41(2):177-84. PubMed ID: 7523001
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and differential diagnosis of pituitary tumours with emphasis on acromegaly.
Hennessey JV; Jackson IM
Baillieres Clin Endocrinol Metab; 1995 Apr; 9(2):271-314. PubMed ID: 7625986
[TBL] [Abstract][Full Text] [Related]
5. Incidence of malignant tumours in patients with a non-functioning pituitary adenoma.
Olsson DS; Hammarstrand C; Bryngelsson IL; Nilsson AG; Andersson E; Johannsson G; Ragnarsson O
Endocr Relat Cancer; 2017 May; 24(5):227-235. PubMed ID: 28274953
[TBL] [Abstract][Full Text] [Related]
6. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
7. Multiple endocrine neoplasia type 1 in patients with recognized pituitary tumours of different types.
Corbetta S; Pizzocaro A; Peracchi M; Beck-Peccoz P; Faglia G; Spada A
Clin Endocrinol (Oxf); 1997 Nov; 47(5):507-12. PubMed ID: 9425388
[TBL] [Abstract][Full Text] [Related]
8. The risks of overlooking the diagnosis of secreting pituitary adenomas.
Brue T; Castinetti F
Orphanet J Rare Dis; 2016 Oct; 11(1):135. PubMed ID: 27716353
[TBL] [Abstract][Full Text] [Related]
9. The epidemiology of pituitary adenomas in Iceland, 1955-2012: a nationwide population-based study.
Agustsson TT; Baldvinsdottir T; Jonasson JG; Olafsdottir E; Steinthorsdottir V; Sigurdsson G; Thorsson AV; Carroll PV; Korbonits M; Benediktsson R
Eur J Endocrinol; 2015 Nov; 173(5):655-64. PubMed ID: 26423473
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study.
Gasperi M; Martino E; Manetti L; Arosio M; Porretti S; Faglia G; Mariotti S; Colao AM; Lombardi G; Baldelli R; Camanni F; Liuzzi A;
J Endocrinol Invest; 2002 Mar; 25(3):240-5. PubMed ID: 11936466
[TBL] [Abstract][Full Text] [Related]
11. Identification of acromegalic patients at risk of developing colonic adenomas.
Bogazzi F; Cosci C; Sardella C; Costa A; Manetti L; Gasperi M; Rossi G; Bartalena L; Martino E
J Clin Endocrinol Metab; 2006 Apr; 91(4):1351-6. PubMed ID: 16449330
[TBL] [Abstract][Full Text] [Related]
12. Pituitary adenomas in patients with multiple endocrine neoplasia type 1: a single-center experience in China.
Wu Y; Gao L; Guo X; Wang Z; Lian W; Deng K; Lu L; Xing B; Zhu H
Pituitary; 2019 Apr; 22(2):113-123. PubMed ID: 30637623
[TBL] [Abstract][Full Text] [Related]
13. Personality in patients with pituitary adenomas is characterized by increased anxiety-related traits: comparison of 70 acromegalic patients with patients with non-functioning pituitary adenomas and age- and gender-matched controls.
Sievers C; Ising M; Pfister H; Dimopoulou C; Schneider HJ; Roemmler J; Schopohl J; Stalla GK
Eur J Endocrinol; 2009 Mar; 160(3):367-73. PubMed ID: 19073833
[TBL] [Abstract][Full Text] [Related]
14. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological significance of baseline T2-weighted signal intensity in functional pituitary adenomas.
Dogansen SC; Yalin GY; Tanrikulu S; Tekin S; Nizam N; Bilgic B; Sencer S; Yarman S
Pituitary; 2018 Aug; 21(4):347-354. PubMed ID: 29460202
[TBL] [Abstract][Full Text] [Related]
16. Increased incidence of euthyroid and hyperthyroid goiters independently of thyrotropin in patients with acromegaly.
Wüster C; Steger G; Schmelzle A; Gottswinter J; Minne HW; Ziegler R
Horm Metab Res; 1991 Mar; 23(3):131-4. PubMed ID: 1907592
[TBL] [Abstract][Full Text] [Related]
17. Increased levels of insulin-like growth factor binding protein-2 in sera and tumours from patients with colonic neoplasia with and without acromegaly.
Miraki-Moud F; Jenkins PJ; Fairclough PD; Jordan S; Bustin SA; Jones AM; Lowe DG; Monson JP; Grossman AB; Besser GM; Camacho-Hübner C
Clin Endocrinol (Oxf); 2001 Apr; 54(4):499-508. PubMed ID: 11318786
[TBL] [Abstract][Full Text] [Related]
18. Increased incidence of neoplasia in females with acromegaly.
Cheung NW; Boyages SC
Clin Endocrinol (Oxf); 1997 Sep; 47(3):323-7. PubMed ID: 9373454
[TBL] [Abstract][Full Text] [Related]
19. Familial Cancer Clustering in Patients with Prolactinoma.
Pekic S; Soldatovic I; Miljic D; Stojanovic M; Doknic M; Petakov M; Popovic V
Horm Cancer; 2019 Feb; 10(1):45-50. PubMed ID: 30196424
[TBL] [Abstract][Full Text] [Related]
20. "Silent" thyrotropin (TSH) expression in acromegaly and clinically non-functioning pituitary adenomas.
Pawlikowski M; Pisarek H; Jaranowska M; Radek M; Winczyk K; Kunert-Radek J
Endokrynol Pol; 2016; 67(5):515-518. PubMed ID: 27403655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]